Related Experiment Videos
[New therapeutics alternative in severe preeclampsia]
Rosa Virgen Pardo-Morales1, Socorro Romero-Figueroa, Gilberto Felipe Vázquez-de Anda
1Unidad de Investigación en Preeclampsia-Eclampsia, Instituto Materno-Infantil del Estado de México, Toluca.
Cirugia Y Cirujanos
|August 18, 2004
Summary
Lumbar epidural blockade effectively controlled diastolic blood pressure in severe preeclampsia patients within six hours. This treatment offers a therapeutic alternative for managing hypertension in these high-risk pregnancies.
Area of Science:
- Obstetrics and Gynecology
- Anesthesiology
- Cardiovascular Physiology
Background:
- Preeclampsia is characterized by vasoconstriction, linked to sympathetic nervous system hyperactivity and elevated catecholamines.
- Vasodilation induced by lumbar epidural blockade can help manage severe preeclampsia-related hypertension.
Purpose of the Study:
- To assess if lumbar epidural blockade with bupivacaine reduces high blood pressure in severe preeclampsia compared to standard treatment.
- To evaluate the efficacy of bupivacaine 0.25% epidural blockade within a 6-hour timeframe.
Main Methods:
- An open-label, randomized controlled trial involving 24 pregnant patients with severe preeclampsia (≥30 weeks gestation).
- Group 1 received standard antihypertensive treatment; Group 2 received lumbar epidural blockade with bupivacaine (10 mg bolus, 5 mg/h infusion).
- Hemodynamic parameters (MAP, SAP, DAP) were monitored non-invasively for 6 hours.
Main Results:
- No significant differences in Mean Arterial Pressure (MAP) or Systolic Arterial Pressure (SAP) between groups.
- Significant differences in Diastolic Arterial Pressure (DAP) were observed in the first and second hours of treatment (p ≤ 0.05).
Conclusions:
- Lumbar epidural blockade with bupivacaine 0.25% is a viable therapeutic option for controlling high blood pressure in severe preeclampsia.
- This method aids in hemodynamic stabilization during the initial 6 hours of management for severe preeclampsia.